Valuation: BioHarvest Sciences Inc.

Market Cap 47.83M 41.31M 38.87M 35.33M 66.44M 4.58B 67.42M 456M 179M 2.29B 180M 176M 7.63B P/E 2026 *
-4x
P/E 2027 * -6.3x
Enterprise Value 47.83M 41.31M 38.87M 35.33M 66.44M 4.58B 67.42M 456M 179M 2.29B 180M 176M 7.63B EV / Sales 2026 *
1.28x
EV / Sales 2027 * 0.96x
Free-Float
85.23%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 68 2026-04-28
Director of Finance/CFO - 2024-10-27
Chief Operating Officer 65 2023-04-18
Director TitleAgeSince
Chairman 68 2018-09-26
Director/Board Member 67 2018-09-26
Director/Board Member 84 2019-02-06
Change 5-day change 1-year change 3-year change Capi.($)
+6.06%-2.94% - - 49.19M
-0.60%-2.62%-12.91%-6.04% 13.18B
-1.10%-2.89%-33.62%-57.05% 4.97B
-0.02%-3.97%+2.16%-0.35% 4.88B
-1.23%-0.41%+4.15%-26.61% 4.22B
-0.83%-2.53%-26.26%+3.70% 3.57B
+0.20%-0.90%-9.74%+15.54% 3.4B
-0.99%-6.39%-9.84%-8.50% 3.32B
-1.93%-0.06%-15.11%-15.88% 2.52B
-4.58%+6.02%-0.65%-10.37% 1.81B
Average -0.50%-2.02%-11.31%-11.73% 4.65B
Weighted average by Cap. -0.88%-2.02%-12.14%-11.89%

Financials

2026 *2027 *
Net sales 37.42M 32.32M 30.41M 27.64M 51.98M 3.59B 52.74M 357M 140M 1.79B 140M 137M 5.97B 49.59M 42.83M 40.3M 36.63M 68.89M 4.75B 69.9M 473M 185M 2.38B 186M 182M 7.92B
Net income -12.02M -10.38M -9.77M -8.88M -16.7M -1.15B -16.94M -115M -44.9M -576M -45.13M -44.15M -1.92B -7.65M -6.61M -6.21M -5.65M -10.62M -733M -10.78M -72.9M -28.57M -366M -28.71M -28.09M -1.22B
Net Debt - -
Logo BioHarvest Sciences Inc.
BioHarvest Sciences Inc. is a Canada-based botanical synthesis company. The Company leverages its technology platform to grow plant-based compounds, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop science-based therapeutic solutions within two major business verticals; as a contract development and manufacturing organization (CDMO) on behalf of customers seeking plant-based compounds, and as a creator of nutraceutical health and wellness products, which include dietary supplements. It delivers phytochemicals such as age-defying antioxidants and polyphenols used for wellness. Its product pipeline is focused on polyphenols, which include grape cells, olive cells, and pomegranate cells. Its process involves selecting the specific plant cells that can create the targeted ingredients. It offers VINIA, which is a nutraceutical containing the entire matrix of polyphenols contained in red grapes, including Piceid resveratrol.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.110USD
Average target price
10.50USD
Spread / Average Target
+397.63%

Quarterly revenue - Rate of surprise